Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02203864
What this trial is testing

Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma

Who this might be right for
Melanoma
Boehringer Ingelheim 49
Early research (Phase 1)Study completedNCT04844775
What this trial is testing

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Who this might be right for
Healthy Adults
ANRS, Emerging Infectious Diseases 68
Large-scale testing (Phase 3)Study completedNCT00662870
What this trial is testing

Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi 1,941
Testing effectiveness (Phase 2)Study completedNCT00831311
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 624
Testing effectiveness (Phase 2)WithdrawnNCT03167177
What this trial is testing

QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy

Who this might be right for
Melanoma
ImmunityBio, Inc.
Not applicableUnknownNCT05166044
What this trial is testing

Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 12,500
Early research (Phase 1)Study completedNCT07342257
What this trial is testing

SYN023 With Rabies Vaccine in Healthy Pediatric Subjects

Who this might be right for
Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd. 108
Not applicableNot Yet RecruitingNCT07141875
What this trial is testing

Child Vaccination Scheduling in China

Who this might be right for
Vaccination Behavior
Peking University 6,000
Testing effectiveness (Phase 2)Study completedNCT01926639
What this trial is testing

Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Oslo University Hospital 14
Early research (Phase 1)Looking for participantsNCT06541639
What this trial is testing

EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors

Who this might be right for
Advanced or Recurrent Solid Tumors
Peking University 78
Early research (Phase 1)Looking for participantsNCT07698600
What this trial is testing

A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 126
Early research (Phase 1)Study completedNCT00257738
What this trial is testing

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)Looking for participantsNCT06057948
What this trial is testing

A Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Who this might be right for
NeuroblastomaHigh-risk NeuroblastomaMetastatic Neuroblastoma
Memorial Sloan Kettering Cancer Center 94
Not applicableStudy completedNCT01583049
What this trial is testing

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Who this might be right for
Diphtheria, Tetanus and Pertussis
Sanofi Pasteur, a Sanofi Company 556
Early research (Phase 1)Study completedNCT02574533
What this trial is testing

Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma

Who this might be right for
Melanoma RecurrentMalignant MelanomaMelanoma
Gradalis, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT01922921
What this trial is testing

Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

Who this might be right for
HER2/Neu PositiveRecurrent Breast CarcinomaStage IV Breast Cancer
University of Washington 31
Testing effectiveness (Phase 2)Study completedNCT00001685
What this trial is testing

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 114
Not applicableStudy completedNCT00004735
What this trial is testing

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 81
Not applicableStudy completedNCT00000943
What this trial is testing

Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)UnknownNCT04564716
What this trial is testing

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

Who this might be right for
Covid19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 100
Next Page